Expression profiles of signal transduction genes in Ex Vivo drug-resistant pediatric acute lymphoblastic leukemia

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 503-506

  Szczepanek, Joanna ^a,b   Pogorzala, Monika ^a   Jarzab, Michal ^c   Oczko Wojciechowska, Malgorzata ^c   Kowalska, Malgorzata ^c   Tretyn, Andrzej ^b   Wysocki, Mariusz ^a   Jarzab, Barbara ^c   Styczynski, Jan ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Drug resistance; Gene expression profile; Microarray; Pediatric acute lymphoblastic leukemia; qRT PCR

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANKYRIN; ASPARAGINE; CALCIUM BINDING PROTEIN; CALGRANULIN A; CALGRANULIN B; CELL ADHESION MOLECULE; ETOPOSIDE; FC RECEPTOR; FLUDARABINE; FORMYLPEPTIDE RECEPTOR LIKE 1; GROWTH HORMONE; INTERLEUKIN 8 RECEPTOR; PREDNISOLONE; PROTEIN S 100; RHO FACTOR; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL; CELL ASSAY; CHILD; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFANT; INTRACELLULAR SIGNALING; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA VIRUS; SCHOOL CHILD; SIGNAL TRANSDUCTION; VALIDATION PROCESS; VIRUS ONCOGENE;

CHILD; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84856894294     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pui CH and Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166-178, 2006. (Pubitemid 43076714)
2. Szczepanek J, Styczynski J, Haus O, Tretyn A and Wysocki M: Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses. Arch Immunol Ther Exp 59: 61 -68, 2011.
3. Bhojwani D, Kang H, Menezes RX, Yang W, Sather H, Moskowitz NP, Min DJ, Potter JW, Harvey R, Hunger SP, Seibel N, Raetz EA, Pieters R, Horstmann MA, Relling MV, den Boer ML, Willman CL and Carroll WL: Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group study. J Clin Oncol 26: 4376-4384, 2008.
4. Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R and Evans WE: Gene expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 357: 533-542, 2004.
5. Szczepanek J, Styczynski J, Haus O, Tretyn A and Wysocki M: Gene expression profiles in acute lymphoblastic leukemia in children and adults. Postepy Hig Med Dosw 67: 519-533, 2007.
6. Galimberti S, Canestraro M, Savli H, Palumbo GA, Tibullo D, Nagy B, Piaggi S, Guerrini F, Cine N, Metelli MR and Petrini M: ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study. Anticancer Res 30: 4525-4535, 2010.
7. Szczepanek J, Pogorzala M, Konatkowska B, Juraszewska E, Badowska W, Olejnik I, Kuzmicz M, Stanczak E, Malinowska I, Stefaniak J, Sobol G, Szczepanski T, Czyzewski K, Wysocki M and Styczynski J: Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia. Anticancer Res 30: 2119-2124, 2010.
8. Ding Q, Stewart J, Jr., Olman MA, Klobe MR and Gladson CL: The pattern of enhancement of SRC kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged. J Biol Chem 275: 39882-39891, 2003. (Pubitemid 37248551)
9. Duxbury MS, Ito H, Zinner MJ, Ashley SW and Whang EE: Sirna directed against c-SRC enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 198: 953-959, 2004. (Pubitemid 38759847)
10. Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D, Hallek M, Van Etten RA and Li S: Requirement of SRC kinases LYN, HCK and FGR for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 36: 453-461, 2004. (Pubitemid 38620028)
11. Yao R, Davidson DD, Lopez-Beltran A, MacLennan GT, Montironi R and Cheng L: The S100 proteins for screening and prognostic grading of bladder cancer. Histol Histopathol 22: 1025-1032, 2007. (Pubitemid 47034168)
12. Murzik U, Hemmerich P, Weidtkamp-Peters S, Ulbricht T, Bussen W, Hentschel J, von Eggeling F and Melle C: RAD54b targeting to DNA double-strand break repair sites requires complex formation with S100A11. Mol Biol Cell 19: 2926-2935, 2008.
13. Sogawa Y, Ohyama T, Maeda H and Hirahara K: Formyl peptide receptor 1 and 2 dual agonist inhibits human neutrophil Chemotaxis by the induction of chemoattractant receptor cross-desensitization. J Pharmacol Sci 115: 63-68, 2011.
14. Yoon HY, Kales SC, Luo R, Lipkowitz S and Randazzo PA: ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol Cell 103: 171-184, 2011.
15. Simova S, Klima M, Cermak L, Sourkova V and Andera L: Arf and rho gap adapter protein arap1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane. Apoptosis 13: 423-436, 2008.
16. Ersoy B, Ozbilgin K, Kasirga E, Inan S, Coskun S and Tuglu I: Effect of growth hormone on small intestinal homeostasis relation to cellular mediators igf-i and igfbp-3. World J Gastroenterol 15: 5418-5424, 2009.
17. Salgin B, Marcovecchio ML, Williams RM, Jackson SJ, Bluck LJ, Humphreys SM, Acerini CL and Dunger DB: Effects of growth hormone and free fatty acids on insulin sensitivity in patients withtype 1 diabetes. J Clin Endocrinol Metab 94: 3297-3305, 2009.